C4 Therapeutics Shares Are Trading Higher After the Company Announced a Strategic Discovery Collaboration With Merck KGaA Against Critical Oncogenic Proteins, in Which the Company Will Receive a $16 Million Upfront Payment
C4 Therapeutics的股價走高,此前該公司宣佈與默沙東KGaA進行鍼對關鍵致癌蛋白的戰略發現合作,該公司將獲得1,600萬美元的預付款